Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$5.19M Sell
19,752
-2,942
-13% -$789K 0.5% 38
2022
Q3
$5.12M Buy
22,694
+7,799
+52% +$1.89M 0.62% 23
2022
Q2
$3.62M Buy
14,895
+1,288
+9% +$316K 0.41% 43
2022
Q1
$3.29M Sell
13,607
-332
-2% -$76.3K 0.33% 63
2021
Q4
$3.13M Buy
13,939
+1,758
+14% +$371K 0.29% 74
2021
Q3
$2.59M Buy
12,181
+286
+2% +$65.8K 0.25% 106
2021
Q2
$2.9M Sell
11,895
-99
-0.8% -$24.4K 0.27% 81
2021
Q1
$2.98M Buy
11,994
+1,652
+16% +$394K 0.3% 62
2020
Q4
$2.38M Sell
10,342
-680
-6% -$157K 0.25% 110
2020
Q3
$2.8M Buy
11,022
+1,342
+14% +$332K 0.3% 72
2020
Q2
$2.28M Buy
9,680
+2,162
+29% +$493K 0.26% 94
2020
Q1
$1.55M Sell
7,518
-1,415
-16% -$309K 0.21% 126
2019
Q4
$2.15M Sell
8,933
-366
-4% -$80.7K 0.23% 143
2019
Q3
$1.8M Sell
9,299
-1,597
-15% -$307K 0.19% 183
2019
Q2
$2.01M Sell
10,896
-847
-7% -$152K 0.21% 162
2019
Q1
$2.23M Buy
11,743
+7,648
+187% +$1.46M 0.21% 156
2018
Q4
$797K Buy
+4,095
New +$799K 0.11% 282

Other funds holding AMGN

Seeyond's AMGN Position: Q4 2022 in Review

Seeyond reduced its Amgen (AMGN) stake by 13% in Q4 2022, selling an estimated $789K and leaving 19,752 shares worth $5.19M. The position accounts for 0.5% of the portfolio, ranked #38.

Seeyond first reported a position in AMGN in Q4 2018 and has held it in 17 quarters since. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Seeyond held 19,752 shares of Amgen worth $5.19M as of Q4 2022.
  • Seeyond sold 2,942 Amgen shares in Q4 2022, an estimated $789K.
  • Amgen made up 0.5% of Seeyond's portfolio in Q4 2022, its #38 holding.
  • Seeyond first reported a position in Amgen in Q4 2018 and has held it in 17 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.